Kent Lake Capital’s Transmedics TMDX Stock Holding History

Kent Lake Capital’s Portfolio TMDX Stock Details TMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-30,000	Closed	-$2.22M	–	54
2024 Q1	$2.22M	Sell	30,000 -25,000	-45%	-$2.06M	0.97%	30
2023 Q4	$4.34M	Sell	55,000 -45,000	-45%	-$2.71M	1.68%	25
2023 Q3	$5.47M	Sell	100,000 -19,129	-16%	-$1.38M	2.11%	23
2023 Q2	$10M	Buy	119,129 +14,229	+14%	+$1.09M	4.6%	4
2023 Q1	$7.94M	Sell	104,900 -145,100	-58%	-$10M	5.37%	5
2022 Q4	$15.4M	Hold	250,000	–	–	9.22%	1
2022 Q3	$10.4M	Sell	250,000 -150,000	-38%	-$6.52M	6.84%	3
2022 Q2	$12.6M	Buy	400,000 +200,000	+100%	+$5.33M	6.92%	1
2022 Q1	$5.39M	Buy	+200,000	New	+$3.58M	3.35%	13

Other funds holding TMDX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Kent Lake Capital's TMDX Position: Q2 2024 in Review

Kent Lake Capital sold out of Transmedics (TMDX) in Q2 2024, closing a stake of 30,000 shares — an estimated $2.22M sold.

Kent Lake Capital first reported a position in TMDX in Q1 2022 and held it in 9 quarters. The position peaked at $15.4M in Q4 2022. 340 funds tracked by Wall St. Rank hold TMDX as of Q2 2024.

Kent Lake Capital reported no remaining Transmedics position as of Q2 2024 after selling out during the quarter.
Kent Lake Capital sold 30,000 Transmedics shares in Q2 2024, an estimated $2.22M.
Kent Lake Capital first reported a position in Transmedics in Q1 2022 and held it in 9 quarters.
Kent Lake Capital's Transmedics position peaked at $15.4M in Q4 2022.
340 funds tracked by Wall St. Rank held Transmedics as of Q2 2024.

Based on Kent Lake Capital's 13F filing for Q2 2024, filed 14 Aug 2024.